ADC Therapeutics

ADC Therapeutics

Verified
Develops proprietary antibody drugs targeting cancer

Company information

Edit
Launch date
Employees
Market cap
$577m
Net debt
-
Firm valuation
$1.7b (Public information from Apr 2021)
Revenues, earnings & profits over time
EUR201620172018201920202021E2022E
Revenues5m4m4m----
% growth-(20 %)-----

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
*
N/ACorporate spinout
$50mSeries A
$40mEarly VC
$80mGrowth Equity VC
$105mGrowth Equity VC
*
$200mSeries E
N/A$76mSeries E
N/A$25mSeries E
*
N/A$268m
Valuation: $1.3b
IPO
Total Funding$576m

Recent News about ADC Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.